STEREOTACTIC RADIOTHERAPY ON BRAIN METASTASES WITH RECENT HEMORRHAGIC SIGNAL: STEREO-HBM, A TWO-STEP PHASE 2 TRIAL

Brain metastases often occur in cancer evolution. They are not only responsible for death but also for disorders affecting the quality of life and the cognitive functions.

4. Design of Low-Delay FIR Filter Bank Pair
In this section a method to design a prototype filter for the SFB is introduced. The main objective lies in obtaining a distortion function of an oversampling I -channel complex- modulated filter bank according to (11) which independ[r]

Background
With 58.000 newly diagnosed cases every year in Germany, prostate cancer is the most common cancer of men in Germany. As the proportion of men older than 60 years is estimated to rise with the demographic shift up to 37% in 2050, prostate cancer will gain more and more epi[r]

Because of the high likelihood of multiple brain metastases (BM) from small cell lung cancer (SCLC), the role of focal treatment using stereotactic radiosurgery (SRS) has yet to be determined. We aimed to evaluate the efficacy and limitations of upfront and salvage SRS for patients with BM from SCLC[r]

High Dose Rate Brachytherapy (HDRB) boost is a well-established treatment for prostate cancer (PC). We describe the PROstate Multicentre External beam radioTHErapy Using Stereotactic boost (PROMETHEUS) study. Non-surgical stereotactic techniques are used to deliver similar doses to HDRB boost regime[r]

Pleural effusions are common and are usually treated with thoracentesis. If they recur and are symptomatic, a pleurex catheter or chest tube drainage followed by pleurodesis with a sclerosing agent such as intrapleural talc, bleomycin, or tetracycline can[r]

commonly, PTH-related peptide; hyponatremia with the syndrome of inappropriate secretion of antidiuretic hormone or possibly atrial natriuretic factor by small cell cancer; and ectopic secretion of ACTH by small cell cancer. ACTH secretion usually results in additional electr[r]

Optimizing patient selection is a necessary step to design better clinical trials. ‘Life expectancy’ is a frequent inclusion criterion in phase II trial protocols, a measure that is subjective and often difficult to estimate. The aim of this study was to identify factors associated with early death[r]

A recent randomized phase II trial evaluated stereotactic ablative radiotherapy (SABR) in a group of patients with a small burden of oligometastatic disease (mostly with 1–3 metastatic lesions), and found that SABR was associated with a significant improvement in progression-free survival and a tren[r]

4.2.5 100Base-T2
The 100Base-T2 system was published by the IEEE in 1996 as the IEEE 802.3y standard but has not been marketed at this stage. It was designed to address the shortcomings of 100Base-T4, making full-duplex 100 Mbps accessible to installations with only two category 3[r]

its NRZI output. The NRZI converted data is passed to the three level code block and the output is then sent to the transceiver. The code words are selectively chosen so the mean line signal line zero, in other words the line is DC balanced.
The three level code results in a low[r]

The routine use of adjuvant whole brain radiotherapy (AWBRT) after surgery or stereotactic radiosurgery is now discouraged by a number of international expert panels. Three decades of randomised studies have shown that, although AWBRT improves radiological measures of intracranial disease control, t[r]

Magnetic resonance imaging (MRI) enables a more sensitive detection of brain metastasis and stereotactic irradiation (SRI) efficiently controls brain metastasis. In limited-stage small cell lung cancer (LS-SCLC), prophylactic cranial irradiation (PCI) in patients with good responses to initial treat[r]

Definition and Pathophysiology
This chapter focuses on imaging within the first few hours of stroke onset, where issues relating to the decision to administer thrombolytics are of paramount importance. Stroke is a clinical term that describes an acute neu- rologic deficit due to a[r]

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced n[r]

Standard radiotherapy is the treatment of first choice in patients with symptomatic spinal metastases, but is only moderately effective. Stereotactic body radiation therapy is increasingly used to treat spinal metastases, without randomized evidence of superiority over standard radiotherapy.

Our aim is to report treatment efficacy and toxicity of patients treated by robotic (Cyberknife®) stereotactic body radiotherapy (SBRT) for oligorecurrent lung metastases (ORLM).

Radiotherapy is an established symptomatic treatment for painful bone metastases, however, when conventional techniques are used, the effectiveness is moderate. Stereotactic body radiotherapy (SBRT), delivering very high doses in a limited number of fractions in a highly conformal manner, could pote[r]

This paper describes the multi-institutional prospective phase II clinical trial, SPARK: Stereotactic Prostate Adaptive Radiotherapy utilizing Kilovoltage Intrafraction Monitoring (KIM). KIM is a real-time image guided radiotherapy technology being developed and clinically pioneered for prostate can[r]

Objectives: To give a description of clinical characteristics of brain magnetic resonance image in patients with brain metastases from non-small cell lung cancer. Subjects and method: A prospective study on 104 patients with brain metastases from non-small cell lung cancer, from 2-2017 to 9-2018.